Stock Code: 000590 Stock Abbreviation: Guhan Pharmaceutical Announcement No.: 2026-029
Guhan Pharmaceutical Group Co., Ltd. Announcement on the Completion of Board of Directors Election and Appointment of Senior Management and Securities Affairs Representative
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Guhan Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") held a staff representative meeting on June 8, 2026, and elected 1 employee director. On June 17, 2026, the Company held its 2025 Annual Shareholders' Meeting, which deliberated and passed the "Proposal on the Election of the Board of Directors of the Company." Six directors, excluding the employee director, were elected, forming the 11th Board of Directors of the Company. On the same day, the Company held the First Meeting of the 11th Board of Directors, electing the Chairman, Vice Chairman of the 11th Board of Directors, members of the specialized committees of the Board of Directors, and appointing senior management personnel and the Securities Affairs Representative. The details are as follows:
I. Composition of the 11th Board of Directors
(I) Board of Directors Chairman: Mr. Jiang Lian Vice Chairman: Mr. Ni Xiaoqiao Board Members
- Non-Independent Directors: Mr. Jiang Shan, Mr. Ni Xiaoqiao (Employee Director), Mr. Zhou Yanqi, Ms. Tang Ting
- Independent Directors: Mr. Lei Zhenhua, Mr. Luo Huaiqing, Ms. Guo Dongfang
(II) Specialized Committees of the Board of Directors
- Strategy Committee: Jiang Shan (Chairman), Ni Xiaoqiao, Zhou Yanqi, Luo Huaiqing, Guo Dongfang
- Audit Committee: Lei Zhenhua (Chairman), Ni Xiaoqiao, Guo Dongfang
- Nomination Committee: Luo Huaiqing (Chairman), Lei Zhenhua, Guo Dongfang
- Remuneration and Appraisal Committee: Guo Dongfang (Chairman), Luo Huaiqing, Lei Zhenhua
The number of directors who concurrently serve as senior management personnel and employee directors on the 11th Board of Directors does not exceed one-half of the total number of directors of the Company. The independent directors have been reviewed and approved by the Shenzhen Stock Exchange without objection. Among them, independent directors constitute the majority and serve as conveners in the Audit Committee, Nomination Committee, and Remuneration and Appraisal Committee. Mr. Lei Zhenhua, Chairman of the Audit Committee, is a professional accountant. The term of office for the members of the specialized committees is consistent with the term of office of the 11th Board of Directors of the Company.
II. Appointment of Senior Management Personnel by the Board of Directors
President: Mr. Jiang Lian Vice Presidents: Ms. Tang Ting, Mr. Wen Ge, Mr. Qiao Xuefeng, Mr. Liu Chengliang Chief Financial Officer: Ms. Tang Ting Secretary of the Board: Mr. Yan Lijun
The term of office for the above personnel is consistent with the term of office of the 11th Board of Directors of the Company.
Mr. Yan Lijun, the Secretary of the Board, has obtained the qualification certificate for Secretary of the Board issued by the Shenzhen Stock Exchange and meets the qualification requirements stipulated by the "Company Law," the "Stock Listing Rules of the Shenzhen Stock Exchange," and other relevant laws, regulations, and the "Articles of Association" of the Company. Contact information is as follows: Contact Number: 0734-8239335 Fax: 0734-8239335 Email: qdyy0008@tuspharma.cn Contact Address: Headquarters Office Building, No. 1, Luojin Bridge, Yanfeng District, Hengyang City, Hunan Province (Yanfeng District Industrial Cluster)
III. Explanation Regarding the Company's Actual Controller Serving Concurrently as Chairman and President
The Company's controlling shareholder and actual controller, Mr. Jiang Shan, concurrently serving as Chairman and President, is a prudent arrangement made in conjunction with the Company's strategic layout and daily operational management needs, which can effectively enhance decision-making coordination efficiency and operational execution.